State Ledger
Company profile

60 DEGREES PHARMACEUTICALS, INC. CIK 1946563

Tickers
SXTP (Nasdaq) · SXTPW (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Washington, DC 20036
Fiscal year end
2025 (FY)
Market Data
Close
$0.88
Change
-$0.01
Change %
-1.22%
Volume
300

SXTP · trading date Oct 13, 2026 · previous close $0.89 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$1.01M
Net income
-$7.37M
Total assets
$5.37M
Total liabilities
$1.99M
Stockholders' equity
$3.46M
Cash & equivalents
$1.51M
Operating income
-$7.76M
Operating cash flow
-$6.85M
Capital expenditures
$139.9K

Fiscal year 2025, via 10-K filed 2026-03-30. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
-771.6%
Net margin
-732.5%
Free cash flow
-$6.99M
Free cash flow margin
-695.1%
Liabilities / assets
37.0%
Equity / assets
64.5%
CapEx / revenue
13.9%
Operating cash flow / net income
0.93×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $1.01M -$7.37M $5.37M $1.99M $3.46M
2024 $607.6K -$7.95M $5.76M $1.80M $4.04M
2023 $253.6K -$3.77M $7.78M $2.99M $4.87M
2022 $223.2K -$6.18M $1.30M $25.45M -$23.58M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-14
Financials filed via
Form 10-K
filed 2026-03-30

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Washington, DC 20036
1025 CONNECTICUT AVENUE NW
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:23 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to District of Columbia — Public Companies